407
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Rituximab preserves vision in ocular mucous membrane pemphigoid

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Delara Amir Dastmalchi, Solmaz Moslemkhani, Maryam Bayat, Kamran Balighi, Robabeh Abedini, Hamidreza Mahmoudi & Maryam Daneshpazhooh. (2022) The efficacy of rituximab in patients with mucous membrane pemphigoid. Journal of Dermatological Treatment 33:2, pages 1084-1090.
Read now

Articles from other publishers (25)

R. Yaïci, M. Roth & G. Geerling. (2023) Okuläres SchleimhautpemphigoidOcular mucous membrane pemphigoid. Die Ophthalmologie 120:7, pages 779-790.
Crossref
Sophia Ly, Dmitry Nedosekin & Henry K. Wong. (2023) Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin. American Journal of Clinical Dermatology 24:2, pages 247-273.
Crossref
Connor Cole & Kyle T. Amber. (2022) Off-Label Uses of Rituximab in Dermatology. Current Dermatology Reports 11:4, pages 209-220.
Crossref
M. Mughees Farooq, Eli M. Miloslavsky, Nellie Konikov & A. Razzaque Ahmed. (2022) Use of rituximab in the treatment of mucous membrane pemphigoid: An analytic review. Autoimmunity Reviews 21:8, pages 103119.
Crossref
Rémi Yaïci, Mathias Roth, Lukas Juergens, Sami Al Nawaiseh, Dick Burkhard, Volker Besgen, Matthias Fuest, Christian Girbardt, Ulrike Hampel, Jens Heichel, Arnd Heiligenhaus, Martina C. Herwig-Carl, Vinodh Kakkassery, Kalliopi Kontopoulou, Karin U. Löffler, Philip Christian Maier, Bernhard Nölle, Johanna Pach, Sebastian Paul, Uwe Pleyer, Michael Pöllmann, Mark Saeger, Enno Schmidt, Sebastian Siebelmann, Ekatarina Sokolenko, Lisa Strudel, Nicole Stübiger, Melih Tarhan, Johanna Theuersbacher, Christian van Oterendorp, Marten Walker, Carolin Wiecha, Agata Anna Wykrota & Gerd Geerling. (2022) Zur Versorgungssituation und konservativen Therapie des okulären vernarbenden Schleimhautpemphigoids in Deutschland. Klinische Monatsblätter für Augenheilkunde.
Crossref
Ariana Ringer, German Daniel Grossi, Carlos Siegrist, Nadia Cuadranti, Juan Pablo Ruffino, María Cecilia Argento, María Florencia Martínez, Daniela Carbone, Serenela Chulibert & Marcelo Abdala. (2022) Ocular cicatricial pemphigoid. From a rheumatology and ophthalmology point of view. Revista Colombiana de Reumatología (English Edition) 29:1, pages 57-67.
Crossref
Ariana Ringer, German Daniel Grossi, Carlos Siegrist, Nadia Cuadranti, Juan Pablo Ruffino, María Cecilia Argento, María Florencia Martínez, Dianela Carbone, Serenela Chulibert & Marcelo Abdala. (2022) Penfigoide ocular cicatrizal, enfoque diagnóstico y terapéutico integral entre el oftalmólogo y el reumatólogo. Revista Colombiana de Reumatología 29:1, pages 57-67.
Crossref
Samir Jabbour, Maria Phylactou & Sajjad Ahmad. (2021) Ocular mucous membrane pemphigoid: novel treatment strategies. Current Opinion in Allergy & Clinical Immunology 21:5, pages 486-492.
Crossref
Amde Selassie Shifera, Gloria H. Hong, Irfan R. Khan, Chinwenwa Okeagu & Jennifer E. Thorne. (2021) Disease Relapse After Drug-Free Remission in Ocular Mucous Membrane Pemphigoid. American Journal of Ophthalmology 223, pages 21-27.
Crossref
Anne Rübsam & Uwe Pleyer. 2021. Entzündliche Augenerkrankungen. Entzündliche Augenerkrankungen 241 254 .
Emily F. Cole, Naveed Sami & Ron J. Feldman. (2020) Updates on diagnosis and management of autoimmune blistering diseases. Giornale Italiano di Dermatologia e Venereologia 155:1.
Crossref
Hideyuki Ujiie, Hiroaki Iwata, Jun Yamagami, Takekuni Nakama, Yumi Aoyama, Shigaku Ikeda, Norito Ishii, Keiji Iwatsuki, Michiko Kurosawa, Daisuke Sawamura, Akiko Tanikawa, Daisuke Tsuruta, Wataru Nishie, Wataru Fujimoto, Masayuki Amagai & Hiroshi Shimizu. (2019) Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). The Journal of Dermatology 46:12, pages 1102-1135.
Crossref
A.-S. Bertrand, O. Dereure, C. Girard, D. Bessis & B. Guillot. (2019) Place du rituximab dans le traitement de la pemphigoïde des muqueuses. Annales de Dermatologie et de Vénéréologie 146:10, pages 659-661.
Crossref
B.S. Daniel & D.F. Murrell. (2019) Review of autoimmune blistering diseases: the Pemphigoid diseases. Journal of the European Academy of Dermatology and Venereology 33:9, pages 1685-1694.
Crossref
Khalaf Kridin, Christine Ahn, William C. Huang, Ahmed Ansari & Naveed Sami. (2019) Treatment Update of Autoimmune Blistering Diseases. Dermatologic Clinics 37:2, pages 215-228.
Crossref
Panagiotis Georgoudis, Francesco Sabatino, Nora Szentmary, Sotiria Palioura, Eszter Fodor, Samer Hamada, Hendrik P. N. Scholl & Zisis Gatzioufas. (2019) Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment. Ophthalmology and Therapy 8:1, pages 5-17.
Crossref
Marcel Wittenberg & Margitta Worm. (2019) Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab. Frontiers in Medicine 6.
Crossref
Kyle T. Amber, Roberto Maglie, Farzan Solimani, Rüdiger Eming & Michael Hertl. (2018) Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs 78:15, pages 1527-1548.
Crossref
Aniek Lamberts, H. Ilona Euverman, Jorrit B. Terra, Marcel F. Jonkman & Barbara Horváth. (2018) Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases. Frontiers in Immunology 9.
Crossref
Caiyun You, Neerav Lamba, Andres F. Lasave, Lina Ma, Mikhail Hernandez Diaz & C. Stephen Foster. (2017) Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study. Graefe's Archive for Clinical and Experimental Ophthalmology 255:6, pages 1221-1228.
Crossref
J K Dart. (2017) The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. Eye 31:2, pages 301-332.
Crossref
Bernhard Steger, Savitha Madhusudan, Stephen B. Kaye, Amira Stylianides, Vito Romano, Sundas E. Maqsood, Janice Harper & Sajjad Ahmad. (2016) Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis—An Interventional Case Series. Cornea 35:12, pages 1611-1614.
Crossref
Alexander Maley, Maxine Warren, Ilyse Haberman, Robert Swerlick, Bhairavi Kharod-Dholakia & Ron Feldman. (2016) Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP). Journal of the American Academy of Dermatology 74:5, pages 835-840.
Crossref
U. Pleyer, D. Pohlmann & N. Stübiger. (2016) Therapie der posterioren, nichtinfektiösen UveitisTreatment of posterior noninfectious uveitis. Der Ophthalmologe 113:5, pages 380-390.
Crossref
. (2016) Rituximab. Reactions Weekly 1583:1, pages 950-950.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.